|
gptkbp:instanceOf
|
gptkb:vaccine
|
|
gptkbp:age
|
adults
children
infants
|
|
gptkbp:alsoKnownAs
|
gptkb:PCV13
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
2009
|
|
gptkbp:ATCCode
|
gptkb:J07AL02
|
|
gptkbp:broadcastOn
|
multiple doses depending on age
|
|
gptkbp:category
|
gptkb:vaccine
|
|
gptkbp:contains
|
pneumococcal polysaccharide conjugates
|
|
gptkbp:containsSerotype
|
gptkb:18C
gptkb:19F
gptkb:23F
1
14
3
4
5
6B
9V
6A
19A
7F
|
|
gptkbp:contraindication
|
severe allergic reaction to previous dose
|
|
gptkbp:countryOfOperation
|
gptkb:European_Union
gptkb:United_States
many other countries
|
|
gptkbp:form
|
suspension for injection
|
|
gptkbp:indication
|
prevention of pneumococcal disease
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
|
gptkbp:numberOfSerotypes
|
13
|
|
gptkbp:prevention
|
gptkb:pneumonia
gptkb:otitis_media
meningitis
bacteremia
|
|
gptkbp:protectedBy
|
gptkb:Streptococcus_pneumoniae
|
|
gptkbp:replacedBy
|
Prevenar (PCV7)
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:sideEffect
|
fever
fatigue
injection site pain
irritability
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:usedIn
|
national immunization programs
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:bfsParent
|
gptkb:Vaccine_business_(to_Pfizer)
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Prevenar 13
|